Alex

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic…

Renesas Introduces Industry’s First General-Purpose 32-bit RISC-V MCUs with Internally Developed CPU Core

RISC-V MCUs Offer Developers a New Low-Power, High-Performance Option along with Full Toolchain Support TOKYO--(BUSINESS…

Operata Has Been Awarded Selection for the Innovation Showcase at Enterprise Connect 2024 (EC24) for Advancing Customer Experience With CX Observability

LAS VEGAS & MELBOURNE, Australia--(BUSINESS WIRE)--#CX--Operata has been awarded selection for the Innovation Showcase at…

TreviPay Introduces New Financing Option and Payment Application Features for B2B Net Terms Programs

New features allow sellers to optimize their order-to-cash process with TreviPay’s managed services and composable…

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

Alibaba Group Cainiao IPO Update and Share Purchase Offer Conference Call

HANGZHOU, China--(BUSINESS WIRE)--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988…

Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration

Patent CN201380038920.6 upheld in response to invalidation challenge DUBLIN--(BUSINESS WIRE)--ERS Genomics Limited, which was formed…

Eutelsat OneWeb Services Activated for Enterprise and Maritime in Australian and New Zealand through Sat One Partnership

First-time activation of land-based services in Australia’s northern and southern regions, maritime services in Australian…

Netcracker Ranked the Overall Leader in Telco Republic’s Next-Generation Telecom Operations and Business Support Systems Market Assessment

Analyst Firm Positions Netcracker as a Disruptive Leader, Highlighting Automation and Monetization Capabilities, Multi-Cloud Strategy…

Osivax Announces Vaccination of Last Patient in Phase 2a Clinical Trial Evaluating OVX836 Combined with QIVs

478 participants were enrolled across Australia Full immunogenicity and safety results expected in the second…